Susan Ph.D. Shiff is of Cara Therapeutics, Inc.. Currently has a direct ownership of 202,085 shares of CARA, which is worth approximately $60,625. The most recent transaction as insider was on Jun 04, 2024, when has been sold 150,647 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 202K
0% 3M change
292.87% 12M change
Total Value Held $60,625

Susan Ph.D. Shiff Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jun 04 2024
BUY
Grant, award, or other acquisition
-
150,647 Added 42.71%
202,085 Common Stock
Jun 01 2023
BUY
Grant, award, or other acquisition
-
32,362 Added 38.62%
51,438 Common Stock
Jun 02 2022
BUY
Grant, award, or other acquisition
-
11,876 Added 38.37%
19,076 Common Stock
Jun 03 2021
BUY
Grant, award, or other acquisition
-
7,200 Added 50.0%
7,200 Common Stock
SPS

Susan Ph.D. Shiff

Stamford, CT

Track Institutional and Insider Activities on CARA

Follow Cara Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells CARA shares.

Notify only if

Insider Trading

Get notified when an Cara Therapeutics, Inc. insider buys or sells CARA shares.

Notify only if

News

Receive news related to Cara Therapeutics, Inc.

Track Activities on CARA